Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
CD40 Pathway Activation Status Predicts Response to CD40 Targeted Therapy in Diffuse Large b-Cell Lymphoma. 51st Annual Meeting and Exposition of the American-Society-of-Hematology Dornan, D., Burington, B., Yue, P., Shi, X., Advani, R., Yu, N., Lau, J. T., Yu, S., de Vos, S., Ansell, S. M., Forero-Torres, A., Modrusan, Z., Koeppen, H., Yang, T., Du, C., Elkins, K., Polson, A. G., Offringa, R., Whiting, N., Ebens, A. J. AMER SOC HEMATOLOGY. 2009: 1065–65
View details for Web of Science ID 000272725803276